You are here

Closed

Reset

NOTE: The Solicitations and topics listed on this site are copies from the various SBIR agency solicitations and are not necessarily the latest and most up-to-date. For this reason, you should visit the respective agency SBIR sites to read the official version of the solicitations and download the appropriate forms and rules.

Displaying 17031 - 17040 of 18931 results
  1. 32.1: Control Technology and Personal Protective Equipment for High Risk Occupations

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    Background: Personal protective equipment (PPE) protects workers from death and disabling injuries and illnesses as well as from the specific threats of exposures to certain airborne biological particles, chemical agents, nanomaterials, splashes, noise exposures, fall hazards, head hazards, and fires. It is estimated that 20 million workers use PPE on a regular basis to protect them from job hazar ...

    SBIRPhase IDepartment of Health and Human Services
  2. 32.2: Exposure Assessment Methods for High Risk Occupations

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    Background: Exposure assessment provides multi-disciplinary strategies and methods to anticipate, recognize, evaluate, control, and confirm effective management of occupational health stressors, exposures to those stressors, and resulting health risks. Major gaps in current approaches include: (1) the lack of practical methods for hazard identification and measurement that can be applied at reason ...

    SBIRPhase IDepartment of Health and Human Services
  3. 32.3: Occupational Traumatic Injuries from Motor Vehicle Crashes and Incidents

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    Background: The risk of roadway crashes and incidents associated with on-the-job operation of motor vehicles affects millions of U.S. workers. Motor vehicle-related incidents are consistently the leading cause of work-related fatalities in the United States. Of approximately 5,700 fatalities annually reported by the Bureau of Labor Statistics, 35% are associated with motor vehicles. The public h ...

    SBIRPhase IDepartment of Health and Human Services
  4. 33: FOOD AND DRUG ADMINISTRATION (FDA)

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    The FDA is responsible for protecting the public health by assuring the safety, efficacy, and security of human and veterinary drugs, biological products, medical devices, our nation’s food supply, cosmetics, and products that emit radiation. The FDA is also responsible for advancing the public health by helping to speed innovations that make medicines and foods more effective, safer, and more a ...

    SBIRPhase IDepartment of Health and Human Services
  5. 33.1: CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER)

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    CBER is responsible for ensuring the safety, efficacy, potency and purity of biological and related products intended for use in the treatment, prevention or cure of diseases in humans as well as the safety of the nation's supply of blood and blood products. The primary responsibility of CBER is to review the quality, safety and efficacy of vaccines, blood products, certain diagnostic products ...

    SBIRPhase IDepartment of Health and Human Services
  6. 33.2: CENTER FOR DRUG EVALUATION AND RESEARCH (CDER)

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    CDER develops FDA policy with regard to the safety, effectiveness, and labeling of all drugs for human use; evaluates new drug applications and investigational new drug applications; develops standards for the safety and effectiveness of all over-the-counter drugs; monitors the quality of marketed drugs through product testing (bioavailability/bioequivalence testing), post marketing surveillance, ...

    SBIRPhase IDepartment of Health and Human Services
  7. 33.3: CENTER FOR FOOD SAFETY AND APPLIED NUTRITION (CFSAN)

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    The FDA is responsible for the safety of the vast range of food Americans eat; about 80 percent of all food sold in the United States. This includes everything except for the meat, poultry, and processed egg products that are regulated by the USDA. Consequently CFSAN seeks research designed to complement and accelerate efforts aimed at the detection, prevention, and control of contamination that m ...

    SBIRPhase IDepartment of Health and Human Services
  8. 33.4: CENTER FOR VETERINARY MEDICINE (CVM)

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    CVM is a public health organization that enables the marketing of effective drugs, food additives, feed ingredients, and animal devices that are safe to animals, humans, and the environment. The Center, in partnership with Federal and state agencies and other customers, ensures animal health and the safety of food derived from animals. The Center makes timely, quality decisions and takes regulator ...

    SBIRPhase IDepartment of Health and Human Services
  9. 33.5: OFFICE OF CRITICAL PATH PROGRAMS

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    The Office of Critical Path Programs, in FDA’s Office of the Chief Scientist, coordinates the cross-agency Critical Path Initiative (CPI), FDA's strategy for transforming the way medical products are developed, evaluated, and manufactured. CPI activities are under way throughout the Agency, from the product centers to the Office of the Commissioner. For details, see http://www.fda.gov/Scienc ...

    SBIRPhase IDepartment of Health and Human Services
  10. 33.6: OFFICE OF ORPHAN PRODUCTS DEVELOPMENT

    Release Date: 01-31-2012Open Date: 03-05-2012Due Date: 01-08-2013Close Date: 01-08-2013

    The Office of Orphan Products Development was established to identify and facilitate the development of orphan products. Orphan products are drugs, biologics, medical devices and foods for medical purposes, which are indicated for a rare disease or condition (i.e., one affecting fewer than 200,000 people in the United States). These products may be useful in a rare disease/disorder but lack commer ...

    SBIRPhase IDepartment of Health and Human Services
US Flag An Official Website of the United States Government